login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock News
USA
- NASDAQ:AVR -
US03675P1021
-
Common Stock
3.78
USD
-0.18 (-4.42%)
Last: 11/11/2025, 8:00:01 PM
3.75
USD
-0.03 (-0.79%)
After Hours:
11/11/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AVR Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Anteris Technologies Global Corp.
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
14 days ago - By: Anteris Technologies Global Corp.
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
14 days ago - By: Anteris Technologies Global Corp.
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
2 months ago - By: Benzinga
- Mentions:
EQX
ETNB
Top 2 Health Care Stocks That May Keep You Up At Night This Month
3 months ago - By: Anteris Technologies Global Corp.
Anteris Announces Results for the Second Quarter of 2025
6 months ago - By: Anteris Technologies Global Corp.
Anteris Announces Results for the First Quarter of 2025
14 days ago - By: Benzinga
- Mentions:
PRE
KIDS
AKBA
NERV
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
15 days ago - By: Anteris Technologies Global Corp.
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
15 days ago - By: Anteris Technologies Global Corp.
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
16 days ago - By: Anteris Technologies Global Corp.
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
16 days ago - By: Anteris Technologies Global Corp.
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
a month ago - By: Anteris Technologies Global Corp.
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
a month ago - By: Anteris Technologies Global Corp.
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
2 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
2 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
2 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
2 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
2 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
2 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
3 months ago - By: Anteris Technologies Global Corp.
Anteris Announces Results for the Second Quarter of 2025
4 months ago - By: Yahoo Finance
- Mentions:
LMAT
Anteris (AVR) Welcomes Two Directors as Major Trial Approaches
5 months ago - By: Anteris Technologies Global Corp.
- Mentions:
LMAT
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
5 months ago - By: Anteris Technologies Global Corp.
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
6 months ago - By: Anteris Technologies Global Corp.
Anteris Announces Results for the First Quarter of 2025
8 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
8 months ago - By: Anteris Technologies Global Corp.
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
8 months ago - By: Anteris Technologies Global Corp.
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
8 months ago - By: Anteris Technologies Global Corp.
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
8 months ago - By: Anteris Technologies Global Corp.
Anteris Reports 2024 Financial Results and Provides Corporate Update
8 months ago - By: Anteris Technologies Global Corp.
Anteris Reports 2024 Financial Results and Provides Corporate Update
9 months ago - By: Anteris Technologies Global Corp.
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
9 months ago - By: Anteris Technologies Global Corp.
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
a year ago - By: Anteris Technologies Global Corp.
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering
Please enable JavaScript to continue using this application.